Literature DB >> 21571793

Cerebral glucose metabolic features of Parkinson disease and incident dementia: longitudinal study.

Nicolaas I Bohnen1, Robert A Koeppe, Satoshi Minoshima, Bruno Giordani, Roger L Albin, Kirk A Frey, David E Kuhl.   

Abstract

UNLABELLED: Longitudinal studies in nondemented Parkinson disease (PD) subjects offer an opportunity to study the earliest regional cerebral subcortical and cortical metabolic changes underlying incident dementia in this disorder.
METHODS: Twenty-three PD subjects without dementia (Hoehn and Yahr stages I-III; age, 61.8 ± 9.7 y; Mini-Mental State Examination, 28.0 ± 1.4) and 27 controls (age, 59.8 ± 11.5 y) underwent (18)F-FDG PET at study entry. PD subjects underwent yearly clinical assessment to determine conversion to dementia. The mean duration of follow-up was 3.9 ± 1.2 y (range, 2.0-6.8 y). Follow-up (18)F-FDG PET was available in a subset of subjects at 2 or more years. Both volume-of-interest and 3-dimensional stereotactic surface projection (3D-SSP) analyses were performed.
RESULTS: Six subjects became demented (PDD), with a mean time of 3.8 ± 1.7 y (range, 1.9-6.0 y) to development of dementia. Mean duration of disease before onset of dementia was 9.7 ± 4.2 y (range, 3.1-14 y). There were significant metabolic reductions in the occipital (-11.8% vs. controls, F((2,22)) = 7.0, P = 0.002) and posterior cingulate (-12.1% vs. controls, F((2,22)) = 5.2, P = 0.009) cortices in PDD subjects at baseline, before diagnosis of dementia, compared with controls. Metabolism was most diminished in the visual association cortex (Brodmann area [BA] 18; -20.0% vs. control, F((2,22)) = 8.45, P = 0.0007) of PDD subjects. There was mild hypometabolism in the caudate nucleus (-8.4% vs. control, F((2,22)) = 3.2, P < 0.05). There was no significant hypometabolism in the temporal or frontal lobes. PD subjects who did not become demented (non-PDD), compared with controls, had reduced cerebral metabolism in the primary occipital cortex (BA 17) that was revealed only by 3D-SSP analysis. Follow-up scans in 5 PDD subjects at 2 y after study entry demonstrated a significant interval within-subject change in the thalamus (-11.4%), posterior cingulate (-9%), occipital (-7%), parietal (-7%), and frontal cortices (-7%) and mild reductions in the temporal cortex (-5%) and hippocampus (-3%), compared with study entry scans.
CONCLUSION: Incident dementia in idiopathic PD is heralded by decreased metabolism in the visual association (BA 18) and posterior cingulate cortices, with mild involvement also of the caudate nucleus. Two-year follow-up data from 5 PDD converters show that progression to dementia is associated with mixed subcortical and cortical changes that involve the mesiofrontal lobes also. These findings provide insights into early metabolic features of parkinsonian dementia.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21571793     DOI: 10.2967/jnumed.111.089946

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  75 in total

1.  Heterogenous mechanisms of mild cognitive impairment in Parkinson's disease.

Authors:  Kurt Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2011-09-30       Impact factor: 3.575

2.  An update on brain imaging in parkinsonian dementia.

Authors:  Myria Petrou; Vikas Kotagal; Nicolaas I Bohnen
Journal:  Imaging Med       Date:  2012-04

3.  Cognitive signature of brain FDG PET based on deep learning: domain transfer from Alzheimer's disease to Parkinson's disease.

Authors:  Hongyoon Choi; Yu Kyeong Kim; Eun Jin Yoon; Jee-Young Lee; Dong Soo Lee
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-11-25       Impact factor: 9.236

Review 4.  The relationship between atrophy and hypometabolism: is it regionally dependent in dementias?

Authors:  María C Rodriguez-Oroz; Belen Gago; Pedro Clavero; Manuel Delgado-Alvarado; David Garcia-Garcia; Haritz Jimenez-Urbieta
Journal:  Curr Neurol Neurosci Rep       Date:  2015-07       Impact factor: 5.081

Review 5.  Molecular Imaging and Updated Diagnostic Criteria in Lewy Body Dementias.

Authors:  Nicolaas I Bohnen; Martijn L T M Müller; Kirk A Frey
Journal:  Curr Neurol Neurosci Rep       Date:  2017-08-14       Impact factor: 5.081

6.  Posterior parietooccipital hypometabolism may differentiate mild cognitive impairment from dementia in Parkinson's disease.

Authors:  David Garcia-Garcia; Pedro Clavero; Carmen Gasca Salas; Isabel Lamet; Javier Arbizu; Rafael Gonzalez-Redondo; Jose A Obeso; Maria C Rodriguez-Oroz
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-08-08       Impact factor: 9.236

Review 7.  The neurobiology and neural circuitry of cognitive changes in Parkinson's disease revealed by functional neuroimaging.

Authors:  Nicola J Ray; Antonio P Strafella
Journal:  Mov Disord       Date:  2012-10-04       Impact factor: 10.338

8.  Distinct manifestation of cognitive deficits associate with different resting-state network disruptions in non-demented patients with Parkinson's disease.

Authors:  Kazuya Kawabata; Hirohisa Watanabe; Kazuhiro Hara; Epifanio Bagarinao; Noritaka Yoneyama; Aya Ogura; Kazunori Imai; Michihito Masuda; Takamasa Yokoi; Reiko Ohdake; Yasuhiro Tanaka; Takashi Tsuboi; Tomohiko Nakamura; Masaaki Hirayama; Mizuki Ito; Naoki Atsuta; Satoshi Maesawa; Shinji Naganawa; Masahisa Katsuno; Gen Sobue
Journal:  J Neurol       Date:  2018-02-01       Impact factor: 4.849

9.  Low Cerebral Glucose Metabolism: A Potential Predictor for the Severity of Vascular Parkinsonism and Parkinson's Disease.

Authors:  Yunqi Xu; Xiaobo Wei; Xu Liu; Jinchi Liao; Jiaping Lin; Cansheng Zhu; Xiaochun Meng; Dongsi Xie; Dongman Chao; Albert J Fenoy; Muhua Cheng; Beisha Tang; Zhuohua Zhang; Ying Xia; Qing Wang
Journal:  Aging Dis       Date:  2015-11-17       Impact factor: 6.745

10.  Regional, kinetic [(18)F]FDG PET imaging of a unilateral Parkinsonian animal model.

Authors:  Matthew D Silva; Charles Glaus; Jacob Y Hesterman; Jack Hoppin; Geraldine Hill Della Puppa; Timothy Kazules; Kelly M Orcutt; Mary Germino; David Immke; Silke Miller
Journal:  Am J Nucl Med Mol Imaging       Date:  2013-03-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.